COMMUNIQUÉS West-GlobeNewswire

BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102
12/02/2018
505(b)(2) application plan acceptable per FDA Application will seek dual indications for opioid and alcohol use disorders ANAHEIM, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a [...]
Advantis Corp. Unexpectedly Set To Triple California Amster-Can Revenue by End of 2nd Quarter
12/02/2018
NEWPORT BEACH, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) is currently working with new and existing partners to more than triple the total California Amster-Can canning production. Two [...]
Avadel Pharmaceuticals Announces Divestiture of Pediatric Business
12/02/2018
Cerecor to acquire Avadel’s pediatric assets Enters into license agreement to develop four LiquiTime ™ or Micropump ® products DUBLIN, Ireland, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL [...]
DBV Technologies présente de nouveaux résultats lors du Congrès Annuel 2018 de l'AAAAI/WAO concernant sa plateforme Viaskin
12/02/2018
Communiqué de presse Montrouge, France, le 12 février 2018 (15h00 CET) DBV Technologies présente de nouveaux résultats lors du Congrès Annuel 2018 de l'AAAAI/WAO concernant sa plateforme Viaskin DBV Technologies ( [...]
DBV Technologies to Highlight Viaskin Technology Platform at the 2018 AAAAI/WAO Joint Congress
12/02/2018
Press Release Montrouge, France, February 12, 2018 DBV Technologies to Highlight Viaskin Technology Platform at the 2018 AAAAI/WAO Joint Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock [...]
Children’s National Health System Selects Artifact Health Mobile Query Platform to Streamline Physician Query Process
12/02/2018
BOULDER, Colo., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Artifact Health , which provides the first and only mobile app that streamlines the physician query process, announced today that Children’s National Health System , [...]
Adamis Pharmaceuticals Announces FDA Acceptance for Review for the Supplemental New Drug Application of Its Low Dose Symjepi Product Candidate
12/02/2018
SAN DIEGO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) (“Company” or “Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has accepted for review the [...]
Cognition Therapeutics to Participate in Leerink Partners 7th Annual Global Healthcare Conference
12/02/2018
PITTSBURGH, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]
Interpace Diagnostics to Present Data on Thyroid, Pancreatic, and Lung Assays
12/02/2018
PARSIPPANY, N.J., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 10 February 2018
12/02/2018
Bagsværd, Denmark, 12 February 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]
Novo Nordisk A/S - Share repurchase programme
12/02/2018
Bagsværd, Denmark, 12 February 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program in Infantile Batten Disease
12/02/2018
NEW YORK and CLEVELAND, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
Abattis awarded a Mitacs grant for R&D of nanoemulsified cannabinoid-rich hemp oil in conjunction with food scientists from the University of British Columbia
12/02/2018
VANCOUVER, British Columbia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce the sponsorship of a research study in partnership with [...]
Dermira Showcases Commitment to Hyperhidrosis Education and Treatment at Leading Dermatology Conference
12/02/2018
MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Celsion Announces ThermoDox® HEAT Study Presentation at Korean Liver Cancer Association’s 12th Annual Scientific Meeting
12/02/2018
LAWRENCEVILLE, N.J., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation today announced that an abstract discussing the Company’s Phase III HEAT study evaluating ThermoDox® in combination with radiofrequency ablation [...]
AzurRx BioPharma Announces Enrollment of Three New Patients for its Phase IIa Study of MS1819-SD
12/02/2018
BROOKLYN, N.Y., Feb. 12, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Rick Van Kirk, CEO of Pro-Dex, Inc. Returns to “Stock Day” with Everett Jolly
12/02/2018
PHOENIX, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Pro-Dex, Inc. (NASDAQ: PDEX ) (“Pro-Dex” the “Company”), CEO Rick Van Kirk joined Everett Jolly on “Stock Day” to review recent accomplishments and 2018 expectations. Pro-Dex [...]
Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including Bavituximab
12/02/2018
TUSTIN, Calif. and BOSTON, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ) (“Avid”) and Oncologie, Inc. today announced that the companies have entered into an Asset Assignment [...]
Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse®
12/02/2018
Positive meeting with the FDA about the resubmission of an NDA for Firdapse Resubmission of NDA for Firdapse on schedule for end of the first quarter CORAL GABLES, Fla., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Catalyst [...]

Pages